Search
for
Sort by
Research 421–450 of 488
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- The Genetic Architecture of Alopecia Areata
- Parsing patterns: Emerging roles of tissue self-organization in health and disease
- MHC Class I-Like MILL Molecules Are β2-Microglobulin-Associated, GPI-Anchored Glycoproteins That Do Not Require TAP for Cell Surface Expression
- Application of Baricitinib in Dermatology
- Mesenchymal Stem Cells Antagonize IFN-Induced Proinflammatory Changes and Growth Inhibition Effects via Wnt/β-Catenin and JAK/STAT Pathway in Human Outer Root Sheath Cells and Hair Follicles
- Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle
- The Roles of Non-coding RNA in the Development and Regeneration of Hair Follicles: Current Status and Further Perspectives
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- The Efficacy and Psychoneuroimmunology Mechanism of Camouflage Combined With Psychotherapy in Vitiligo Treatment
- Baricitinib for the Treatment of Alopecia Areata
- The Multi-Faceted Role of Gut Microbiota in Alopecia Areata
- Identifying effective immune biomarkers in alopecia areata diagnosis based on machine learning methods
- The genetic link between thyroid dysfunction and alopecia areata: a bidirectional two-sample Mendelian randomization study
- A novel predictive model for the recurrence of pediatric alopecia areata by bioinformatics analysis and a single-center prospective study
- Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarrier Controls Chemotherapy-Induced Alopecia Areata
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Gut microbiome, metabolome and alopecia areata
- Design and Characterization of Baricitinib Incorporated PLA 3D Printed Pills by Fused Deposition Modeling: An Oral Pill for Treating Alopecia Areata
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Study of the Thyroid Profile of Patients with Alopecia
- Role and Mechanisms of Phytochemicals in Hair Growth and Health
- Mesenchymal Stem Cells for the Treatment of Skin Diseases
- Efficacy of Local and Whole‐Body Phototherapy for the Treatment of Various Types of Alopecia Areata
- Fractionated CO2 Laser in Combination with Topical Tacrolimus for Chronic Alopecia Areata: A Case Series Study
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Management of Alopecia Areata through Unani Medicine